Full Year 2024 Select, Preliminary, Unaudited Financial Results…Sees revenue of approximately $693M, representing approximately 30% growth year-over-year;Continued improvement in adjusted EBITDA compared to the prior year… sees Q EPS , consensus
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEM:
- Tempus AI teams with Genialis to develop RNA-based biomarker algorithms
- Tempus AI up after FDA issues draft guidance on AI use in drug decision making
- tempus AI Inc Class A call volume above normal and directionally bullish
- Cathie Wood’s ARK Investment bought 348K shares of Tempus AI today
- Cathie Wood’s ARK Investment bought 335.7K shares of Tempus AI today